1. Definition and clinical relevance
The National Immunisation Program (NIP) is a federally funded schedule providing free vaccines to all eligible Australian children from birth through adolescence. It protects against a defined set of vaccine-preventable diseases and is updated periodically as new vaccines are added or evidence shifts. For an Australian intern, familiarity with the schedule is essential because you will encounter questions about missed doses, catch-up planning, vaccine administration technique, contraindications, and school-based programs across general practice, emergency, and paediatric settings. Vaccine-preventable disease outbreaks (particularly pertussis and measles) remain a real clinical risk in under-immunised communities, making timely identification of immunisation gaps a patient safety issue.
2. Key values, thresholds, scoring systems
Standard NIP Schedule (from 2018 onward)
| Age | Vaccines given |
|---|---|
| Birth | Hepatitis B (HepB) |
| 2 months | DTPa, Hib, HepB, IPV, pneumococcal (13vPCV), rotavirus |
| 4 months | DTPa, Hib, HepB, IPV, pneumococcal (13vPCV), rotavirus |
| 6 months | DTPa, Hib, HepB, IPV |
| 12 months | MMR, pneumococcal (13vPCV), meningococcal ACWY |
| 18 months | DTPa, varicella, MMR (second dose), Hib |
| 4 years | DTPa, IPV |
| School programs (approx. 12-13 years) | HPV (2-dose series), dTpa (adolescent booster), meningococcal ACWY |
Key thresholds
| Parameter | Value |
|---|---|
| Minimum interval between two different live vaccines if not given together | 4 weeks |
| Vaccine storage temperature | 2 to 8 degrees C (cold chain mandatory) |
| Defer immunisation if fever exceeds | 38.5 degrees C |
| Also defer if | Active vomiting or diarrhoea, or child clearly unwell |
| Adult diphtheria-tetanus (dT/ADT) booster interval | Every 10 years |
| Pertussis booster in pregnancy | Third trimester (any time in pregnancy for influenza) |
3. Approach: presentation and differential
History red flags suggesting immunisation gap
Ask about: country of birth and prior vaccination records, previous severe reactions to any vaccine, current or recent immunosuppressive therapy (systemic steroids, chemotherapy, haematological malignancy), household contacts who are immunocompromised, pregnancy status in adolescent females, and any live vaccine received within the preceding four weeks.
A child presenting with prolonged paroxysmal cough should prompt consideration of pertussis even if partially vaccinated. Measles must be considered in any febrile child with coryza, conjunctivitis, and rash, particularly in those with incomplete MMR coverage. Invasive pneumococcal disease or Hib meningitis in a young child warrants urgent review of vaccination history.
Differential for "child not up to date with vaccines"
- Genuinely missed doses (most common): no medical contraindication, simply not attended.
- Parental vaccine hesitancy: requires non-judgmental counselling addressing specific concerns.
- True contraindication: severe anaphylaxis to a prior dose or to a vaccine component; live vaccines in significantly immunocompromised children.
- Overseas-born child or refugee: records may be incomplete, in another language, or absent entirely.
- Premature infant: schedule runs from chronological age, not corrected age; doses are not delayed because of prematurity.
4. Investigations
Before immunisation
A structured pre-immunisation questionnaire should be used at every visit. It should cover prior severe reactions, immune status, household immunocompromise, possible pregnancy, and recent live vaccines.
Serological checks in specific groups
| Group | Test |
|---|---|
| Refugees and overseas-born children | Review all available records; check HepB surface antigen and antibody |
| Women of reproductive age (refugee or incompletely vaccinated) | Rubella IgG antibody |
| Individuals over 14 years with uncertain varicella history | Varicella IgG antibody |
| Newborns of HepB surface antigen-positive mothers | HepB surface antigen and antibody at 12 months |
Australian Immunisation Register (AIR)
All vaccine doses must be recorded in the AIR (formerly the Australian Childhood Immunisation Register, established 1996). Overseas records and pre-departure vaccination documents should be reviewed and uploaded. The AIR generates reminder notices and is used to determine eligibility for certain family payments linked to immunisation milestones.
5. Management
Vaccine administration technique
Injection site selection matters clinically. In infants younger than 12 months, intramuscular vaccines go into the anterolateral thigh, specifically at the junction of the upper and middle thirds. When two separate intramuscular injections are needed simultaneously, each goes into a different thigh. In children older than 12 months and in adults, the deltoid muscle of the upper arm is the preferred intramuscular site.
Do not postpone vaccination for minor illness such as a mild upper respiratory tract infection without fever. Defer only if temperature exceeds 38.5 degrees C, if the child has active gastroenteritis, or if they appear significantly unwell.
Live vaccines: co-administration rule
Two different live attenuated vaccines (for example, MMR and varicella) may be administered on the same visit. If they cannot be given at the same appointment, a minimum four-week gap must be observed before the second live vaccine is given. Failure to observe this interval may blunt the immune response to the second vaccine.
Catch-up immunisation
When a child has missed doses, the schedule does not restart from the beginning. The number of doses already received counts, and the child continues from where they left off, using age-appropriate minimum intervals. No additional doses beyond the standard total are required simply because doses were delayed. A catch-up schedule should be individualised, documented in the AIR, and followed up actively.
For children with no records at all (common in refugees), serological testing for specific antigens (HepB, rubella, varicella) can guide which vaccines are genuinely needed. For antigens without a practical serological test, it is generally safer to re-vaccinate than to leave gaps.
School-based programs
State and territory health departments deliver school-based programs, typically in years 7 to 10. The core vaccines delivered through these programs are:
- HPV vaccine: a two-dose series for both males and females, protecting against oncogenic HPV strains responsible for cervical, oropharyngeal, anal, and other anogenital cancers.
- Adolescent dTpa booster: covers diphtheria, tetanus, and acellular pertussis.
- Meningococcal ACWY: a single dose targeting serogroups A, C, W, and Y.
Students who miss school-based sessions can receive these vaccines through their GP or council immunisation service, funded through the NIP.
Pertussis-specific management note
The primary pertussis series is given at two, four, and six months of age, with a booster at four years and again in mid-adolescence (approximately 15 to 17 years). Close contacts of a confirmed pertussis case should receive a seven-day course of antibiotics regardless of their vaccination status, provided this is started within three weeks of cough onset. Infants under six months with pertussis often require hospital admission because of apnoea risk.
Pregnancy
Influenza vaccine is recommended at any point during pregnancy. A pertussis-containing booster (dTpa) is recommended in the third trimester of each pregnancy to provide passive antibody transfer to the neonate before the infant's own primary series begins. Live vaccines (MMR, varicella) are contraindicated during pregnancy.
Vaccine storage
All vaccines must be stored continuously between 2 and 8 degrees C. Cold chain breaches must be reported and affected vaccines quarantined pending advice. Maximum-minimum thermometers are required for continuous monitoring of storage units.
Consent
Valid informed consent is required before each immunisation episode. Parents or guardians must be given information about the benefits of vaccination, the risks of the relevant vaccine-preventable diseases, and the common adverse effects expected. This should be provided in written form where possible.
6. Australian-specific considerations
Aboriginal and Torres Strait Islander children
Aboriginal and Torres Strait Islander children have additional vaccines funded through the NIP because of higher rates of invasive pneumococcal disease, hepatitis A, and other infections in some communities. In areas of high endemicity, hepatitis A vaccine is scheduled from 18 months. Some regions also fund additional pneumococcal doses. When providing immunisation services in these communities, culturally safe practice means engaging with families and community health workers, explaining the purpose of each vaccine in plain language, and ensuring records are entered into the AIR so continuity is maintained when families move between communities or to urban centres. Catch-up rates in remote communities can lag behind metropolitan rates, so proactive recall and outreach vaccination are important.
Rural and remote considerations
Cold chain maintenance is more challenging in remote settings. Vaccine delivery may depend on scheduled outreach clinics or Royal Flying Doctor Service visits. Telehealth can support parents and community health workers in identifying immunisation gaps and planning catch-up, but the physical administration of vaccines still requires a trained provider on site. Retrieval is not relevant to routine immunisation but is critical if a severe anaphylactic reaction occurs in a setting without immediate resuscitation backup: adrenaline 0.01 mg/kg intramuscularly (maximum 0.5 mg) must be available at every immunisation session, and the child must be observed for at least 15 minutes post-vaccination.
Refugees and migrants
Almost all children arriving from refugee backgrounds require catch-up vaccination. Overseas records should be reviewed carefully: some countries use different vaccine schedules, different combination products, or have lower coverage rates. All records should be translated, verified where possible, and entered into the AIR. Serological testing for HepB, rubella, and varicella (in older children) helps avoid unnecessary doses while identifying genuine gaps. Children from countries with high H. pylori prevalence may also present with failure to thrive, which can complicate the clinical picture during the immunisation review visit.
Financial and administrative considerations
Family payments linked to immunisation milestones (the "immunisation milestone" requirements for certain Centrelink payments) mean that incomplete immunisation records can have financial consequences for families. Helping families update the AIR with overseas records or catch-up doses can directly affect their eligibility. MBS item 715 (annual health assessment for Aboriginal and Torres Strait Islander people) includes immunisation review as a component.
Clinical pearls
- A missed or delayed vaccine never means the schedule restarts: count what has been given and continue forward, using appropriate minimum intervals.
- Two live vaccines must either be given at the same visit or separated by a minimum of four weeks; giving them one to three weeks apart risks an inadequate immune response to the second.
- Fever above 38.5 degrees C, active vomiting or diarrhoea, or obvious systemic illness are the main valid reasons to defer vaccination; a mild runny nose is not.
- In premature infants, the immunisation schedule runs from chronological (birth) age, not corrected gestational age: a 28-weeker gets their two-month vaccines at eight weeks of life.
- Every immunisation session requires adrenaline immediately available: anaphylaxis, though rare, can occur within minutes and must be treated on the spot before any transfer.
- Refugee children arriving without records should be assumed under-vaccinated: serological testing for HepB, rubella, and varicella guides targeted catch-up rather than blanket re-vaccination for everything.